• UFC 146

Overeem cites medication for positive test

ESPN staff
April 23, 2012

Alistair Overeem has issued a statement explaining that medication was to blame for the high testosterone to epitestosterone ratio that forced him to withdraw from UFC 146.

Overeem's test reported a 14:1 ratio and the heavyweight fighter, who had been set to take on champion Junior Dos Santos, claims that was due to a doctor-prescribed anti-inflammatory.

He now hopes that by withdrawing his fight licence application, he will avoid the prospect of having his application rejected, which would mean a year's wait before he can apply again. However, the Nevada State Athletic Commission can reject his motion for withdrawal if it so wishes.

Overeem's statement read: "I am deeply saddened to announce that on Friday, April 20, I respectfully withdrew from the May 26 event so that I can request a continuance until my situation with the Nevada State Athletic Commission is resolved.

"I cannot express how sorry I am to the Commission, Junior Dos Santos, the fans, the owners and employees of the UFC, my friends and family and anyone else who this has affected.

"I absolutely do not believe in, nor do I use performance-enhancing drugs. I am a clean fighter and I will do whatever it takes to prove this to everyone.

"Prior to the UFC 146 press conference in March, I aggravated an old rib injury on my left side. My doctor prescribed, and I accepted, an anti-inflammatory medication that was mixed with testosterone. I was completely unaware that testosterone was one of the ingredients in the medication. Although I was unaware, I do realise it is my job to know what I am putting into my body.

"I respect the Nevada Commissioners and executive director Keith Kizer and what they are doing to keep the sport of mixed martial arts regulated and safe for athletes. I look forward to working with them in the days and weeks ahead.

"Friends and fans, I ask for your patience as I work through this matter. Please support me. I promise to return to the Octagon soon."

© ESPN Sports Media Ltd.
Close